Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$883M |
| 2 |
Microsoft
MSFT
|
+$870M |
| 3 |
Amazon
AMZN
|
+$600M |
| 4 |
Meta Platforms (Facebook)
META
|
+$343M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.4M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$32.8M |
| 3 |
LPT
Liberty Property Trust
LPT
|
+$29.6M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$12.9M |
| 5 |
INXN
Interxion Holding N.V.
INXN
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.71% |
| 2 | Healthcare | 16.11% |
| 3 | Consumer Discretionary | 11.47% |
| 4 | Communication Services | 10.62% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
First Hawaiian
FHB
$3.38B
| $4.2M | ﹤0.01% |
254,067
-1,100
| -0.4% | -$27.8K |
|
1027
UMB Financial
UMBF
$11.5B
| $4.2M | ﹤0.01% |
90,500
+1,300
| +1% | +$79.1K |
|
1028
iRhythm Holdings
IRTC
$4.13B
| $4.17M | ﹤0.01% |
51,300
+3,700
| +8% | +$307K |
|
1029
Bank OZK
OZK
$5.73B
| $4.17M | ﹤0.01% |
249,433
+3,300
| +1% | +$84.8K |
|
1030
Agios Pharmaceuticals
AGIO
$1.96B
| $4.15M | ﹤0.01% |
116,960
+1,500
| +1% | +$69.3K |
|
|
GRA
1031
DELISTED
W.R. Grace & Co.
GRA
| $4.15M | ﹤0.01% |
116,500
+1,600
| +1% | +$91.4K |
|
|
CRON
1032
Cronos Group
CRON
$1.13B
| $4.13M | ﹤0.01% |
739,700
+90,300
| +14% | +$600K |
|
1033
Columbia Sportswear
COLM
$2.92B
| $4.11M | ﹤0.01% |
58,900
+700
| +1% | +$59.4K |
|
|
PACW
1034
DELISTED
PacWest Bancorp
PACW
| $4.11M | ﹤0.01% |
229,273
+3,000
| +1% | +$94K |
|
1035
LiveRamp
RAMP
$2.31B
| $4.11M | ﹤0.01% |
124,700
+1,400
| +1% | +$53.1K |
|
|
STL
1036
DELISTED
Sterling Bancorp
STL
| $4.11M | ﹤0.01% |
392,864
| – | – |
|
1037
Medpace
MEDP
$16.2B
| $4.1M | ﹤0.01% |
55,900
+1,200
| +2% | +$104K |
|
1038
Sabra Healthcare REIT
SBRA
$5.16B
| $4.1M | ﹤0.01% |
375,641
+12,800
| +4% | +$236K |
|
1039
First Citizens BancShares
FCNCA
$25.8B
| $4.09M | ﹤0.01% |
12,300
-300
| -2% | -$139K |
|
|
PCH
1040
DELISTED
PotlatchDeltic
PCH
| $4.09M | ﹤0.01% |
130,422
+1,700
| +1% | +$65.8K |
|
|
STMP
1041
DELISTED
Stamps.com, Inc.
STMP
| $4.09M | ﹤0.01% |
31,466
+300
| +1% | +$31.4K |
|
1042
Webster Financial
WBS
$12.8B
| $4.09M | ﹤0.01% |
178,500
+2,000
| +1% | +$81.4K |
|
|
ARNA
1043
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.08M | ﹤0.01% |
97,230
+1,900
| +2% | +$87.1K |
|
1044
EnerSys
ENS
$7.5B
| $4.06M | ﹤0.01% |
82,000
+700
| +0.9% | +$45.7K |
|
1045
GATX Corp
GATX
$6.36B
| $4.06M | ﹤0.01% |
64,900
| – | – |
|
|
IMMU
1046
DELISTED
Immunomedics Inc
IMMU
| $4.04M | ﹤0.01% |
300,050
+6,100
| +2% | +$103K |
|
1047
Rithm Capital
RITM
$5.8B
| $4.04M | ﹤0.01% |
805,805
+10,500
| +1% | +$152K |
|
1048
Freshpet
FRPT
$3.5B
| $4.02M | ﹤0.01% |
62,950
+800
| +1% | +$51.4K |
|
1049
Howard Hughes
HHH
$3.97B
| $4.02M | ﹤0.01% |
83,500
+1,258
| +2% | +$126K |
|
|
MYOK
1050
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $3.99M | ﹤0.01% |
85,090
+1,300
| +2% | +$83.3K |
|
Similar funds
Swiss National Bank's Q1 2020 Portfolio in Review
As of Q1 2020, Swiss National Bank held 2,510 positions worth $94.2B, down 3.4% from $97.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Swiss National Bank deployed $18.4B of net new capital in Q1 2020, opening 4 new positions and adding to 1,998 existing holdings. Its largest new stake was Luckin Coffee Inc. American Depositary Shares: 165,417 shares worth $4.5M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was C.H. Robinson, an estimated $5.64M trimmed.
- Swiss National Bank's largest Q1 2020 buy was Luckin Coffee Inc. American Depositary Shares: 165,417 shares worth $4.5M.
- Swiss National Bank added most to Apple in Q1 2020, an estimated $883M increase.
- Swiss National Bank's biggest Q1 2020 reduction was C.H. Robinson, cutting an estimated $5.64M.
- Swiss National Bank fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $52.4M.
- Swiss National Bank's ten largest holdings make up 22% of its $94.2B portfolio in Q1 2020.
- Swiss National Bank opened 4 new positions and closed 30 in Q1 2020.
- Swiss National Bank's portfolio value fell 3.4% quarter-over-quarter to $94.2B.
Based on Swiss National Bank's 13F filing for Q1 2020, filed 8 May 2020.